Skip to main content
SpringerLink
Log in

Repeat Hepatectomy for Colorectal Liver Metastases

  • Chapter
  • First Online:
Gastrointestinal Malignancies

Part of the book series: Cancer Treatment and Research ((CTAR))

Abstract

Surgical resection of hepatic metastatic disease from colorectal cancer offers the best survival advantage when compared to other treatment modalities as survival from unresected disease is rare. Even after adequate surgical excision of colorectal cancer, 20–40 % of patients will develop recurrent disease to the liver. This chapter discusses the management of patients with recurrent colorectal metastases to the liver after initial resection and offers strategies to optimize and guide their treatment with a multimodality approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society (2015). Cancer facts & figures 2015

    Google Scholar 

  2. Steele G Jr, Ravikumar TS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210:127–138

    Article  PubMed  PubMed Central  Google Scholar 

  3. Welch JP, Donaldson GA (1979) The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189:496–502

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59–71

    Article  CAS  PubMed  Google Scholar 

  5. Sugarbaker PH (1990) Surgical decision making for large bowel cancer metastatic to the liver. Radiology 174:621–626

    Article  CAS  PubMed  Google Scholar 

  6. Altendorf-Hofmann A, Scheele J (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12:165–192 (xi)

    Google Scholar 

  7. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13–29

    CAS  PubMed  Google Scholar 

  8. Moertel CG, Gunderson LL, Mailliard JA et al (1994) Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The north central cancer treatment group. J Clin Oncol 12:21–27

    CAS  PubMed  Google Scholar 

  9. Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23–30

    Article  CAS  PubMed  Google Scholar 

  10. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947

    PubMed  Google Scholar 

  11. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  CAS  PubMed  Google Scholar 

  12. Bentrem DJ, Dematteo RP, Blumgart LH (2005) Surgical therapy for metastatic disease to the liver. Annu Rev Med 56:139–156

    Article  CAS  PubMed  Google Scholar 

  13. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246

    Article  CAS  PubMed  Google Scholar 

  14. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–1410

    Article  CAS  PubMed  Google Scholar 

  15. Bozzetti F, Doci R, Bignami P, Morabito A, Gennari L (1987) Patterns of failure following surgical resection of colorectal cancer liver metastases. rationale for a multimodal approach. Ann Surg 205:264–270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C (1987) Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 205:256–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ekberg H, Tranberg KG, Andersson R et al (1987) Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 11:541–547

    Article  CAS  PubMed  Google Scholar 

  18. Pinson CW, Wright JK, Chapman WC, Garrard CL, Blair TK, Sawyers JL (1996) Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 223:765–73 (discussion 773-6)

    Google Scholar 

  19. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pawlik TM, Choti MA (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 11:1057–1077

    Article  PubMed  Google Scholar 

  21. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125–135

    Article  PubMed  Google Scholar 

  22. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–18 (discussion 318-21)

    Google Scholar 

  23. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586–589

    Article  CAS  PubMed  Google Scholar 

  24. Petrowsky H, Gonen M, Jarnagin W et al (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann Surg 235:863–871

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nakamura S, Sakaguchi S, Nishiyama R et al (1992) Aggressive repeat liver resection for hepatic metastases of colorectal carcinoma. Surg Today 22:260–264

    Article  CAS  PubMed  Google Scholar 

  26. Stone MD, Cady B, Jenkins RL, McDermott WV, Steele Jr. GD (1990) Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 125:718–721 (discussion 722)

    Google Scholar 

  27. Nordlinger B, Vaillant JC, Guiguet M et al (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association francaise de chirurgie. J Clin Oncol 12:1491–1496

    CAS  PubMed  Google Scholar 

  28. Malik HZ, Gomez D, Wong V et al (2007) Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol 33:1003–1009

    Article  CAS  PubMed  Google Scholar 

  29. Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–25 (discussion 825-7)

    Google Scholar 

  30. Fegiz G, Ramacciato G, Gennari L et al (1991) Hepatic resections for colorectal metastases: the italian multicenter experience. J Surg Oncol Suppl 2:144–154

    Article  CAS  PubMed  Google Scholar 

  31. Finlay IG, McArdle CS (1986) Occult hepatic metastases in colorectal carcinoma. Br J Surg 73:732–735

    Article  CAS  PubMed  Google Scholar 

  32. Asiyanbola B, Chang D, Gleisner AL et al (2008) Operative mortality after hepatic resection: Are literature-based rates broadly applicable? J Gastrointest Surg 12:842–851

    Article  PubMed  Google Scholar 

  33. Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109:718–726

    Article  PubMed  Google Scholar 

  34. Menon KV, Al-Mukhtar A, Aldouri A, Prasad RK, Lodge PA, Toogood GJ (2006) Outcomes after major hepatectomy in elderly patients. J Am Coll Surg 203:677–683

    Article  PubMed  Google Scholar 

  35. Aldrighetti L, Arru M, Calori G et al (2004) Impact of age on the outcome of liver resections. Am Surg 70:453–460

    PubMed  Google Scholar 

  36. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373–379

    Article  PubMed  PubMed Central  Google Scholar 

  37. Brand MI, Saclarides TJ, Dobson HD, Millikan KW (2000) Liver resection for colorectal cancer: Liver metastases in the aged. Am Surg 66:412–5; discussion 415-416

    Google Scholar 

  38. Adam R, Pascal G, Castaing D et al (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052–61 (discussion 1061-4)

    Google Scholar 

  39. Vauthey JN, Pawlik TM, Abdalla EK et al (2004) Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239:722–30 (discussion 730-2)

    Google Scholar 

  40. Gayowski TJ, Iwatsuki S, Madariaga JR et al (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703–10 (discussion 710-1)

    Google Scholar 

  41. Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722 (discussion 722-4)

    Google Scholar 

  42. Nuzzo G, Giuliante F, Ardito F et al (2008) Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery. 143:384–393

    Article  PubMed  Google Scholar 

  43. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626–637

    PubMed  Google Scholar 

  44. Welsh FK, Tekkis PP, O’Rourke T, John TG, Rees M (2008) Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making. Surg Oncol 17:3–13

    Article  PubMed  Google Scholar 

  45. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348–1353

    Article  PubMed  Google Scholar 

  46. Adam R, Bismuth H, Castaing D et al (1997) Repeat hepatectomy for colorectal liver metastases. Ann Surg 225:51–60 (discussion 60-2)

    Google Scholar 

  47. Ishiguro S, Akasu T, Fujimoto Y et al (2006) Second hepatectomy for recurrent colorectal liver metastasis: analysis of preoperative prognostic factors. Ann Surg Oncol 13:1579–1587

    Article  PubMed  Google Scholar 

  48. Fortner JG, Kim DK, Maclean BJ et al (1978) Major hepatic resection for neoplasia: Personal experience in 108 patients. Ann Surg 188:363–371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Bozzetti F, Bignami P, Montalto F, Doci R, Gennari L (1992) Repeated hepatic resection for recurrent metastases from colorectal cancer. Br J Surg 79:146–148

    Article  CAS  PubMed  Google Scholar 

  50. Muratore A, Polastri R, Bouzari H, Vergara V, Ferrero A, Capussotti L (2001) Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol 76:127–132

    Article  CAS  PubMed  Google Scholar 

  51. Sa Cunha A, Laurent C, Rault A, Couderc P, Rullier E, Saric J (2007) A second liver resection due to recurrent colorectal liver metastases. Arch Surg 142:1144–1149 (discussion 1150)

    Google Scholar 

  52. Rocklin MS, Senagore AJ, Talbott TM (1991) Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis Colon Rectum 34:794–797

    Article  CAS  PubMed  Google Scholar 

  53. Wanebo HJ, Llaneras M, Martin T, Kaiser D (1989) Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. Surg Gynecol Obstet 169:479–487

    CAS  PubMed  Google Scholar 

  54. Beart RW Jr, Metzger PP, O’Connell MJ, Schutt AJ (1981) Postoperative screening of patients with carcinoma of the colon. Dis Colon Rectum 24:585–588

    Article  PubMed  Google Scholar 

  55. Wanebo JH, Stearns M, Schwartz MK (1978) Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 188:481–493

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Glover C, Douse P, Kane P et al (2002) Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 45:476–484

    Article  CAS  PubMed  Google Scholar 

  57. Metcalfe M, Mann C, Mullin E, Maddern G (2005) Detecting curable disease following hepatectomy for colorectal metastases. ANZ J Surg. 75:524–527

    Article  PubMed  Google Scholar 

  58. Watson AJ, Lolohea S, Robertson GM, Frizelle FA (2007) The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 50:102–114

    Article  CAS  PubMed  Google Scholar 

  59. Delbeke D, Vitola JV, Sandler MP et al (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201

    CAS  PubMed  Google Scholar 

  60. Ogunbiyi OA, Flanagan FL, Dehdashti F et al (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620

    Article  CAS  PubMed  Google Scholar 

  61. Valk PE, Abella-Columna E, Haseman MK et al (1999) Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 134:503–511 (discussion 511-3)

    Google Scholar 

  62. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756

    Article  PubMed  Google Scholar 

  63. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ (2005) The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104:2658–2670

    Article  PubMed  Google Scholar 

  64. Lonneux M, Reffad AM, Detry R, Kartheuser A, Gigot JF, Pauwels S (2002) FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 29:915–921

    Article  PubMed  Google Scholar 

  65. Schiepers C, Penninckx F, De Vadder N et al (1995) Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 21:517–522

    Article  CAS  PubMed  Google Scholar 

  66. Whiteford MH, Whiteford HM, Yee LF et al (2000) Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759–767 (discussion 767-70)

    Google Scholar 

  67. Tanaka T, Kawai Y, Kanai M, Taki Y, Nakamoto Y, Takabayashi A (2002) Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg 184:433–436

    Article  PubMed  Google Scholar 

  68. Strasberg SM, Dehdashti F, Siegel BA, Drebin JA, Linehan D (2001) Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg 233:293–299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Desai DC, Zervos EE, Arnold MW, Burak WE Jr, Mantil J, Martin EW Jr (2003) Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol 10:59–64

    Article  PubMed  Google Scholar 

  70. Vitola JV, Delbeke D, Sandler MP et al (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171:21–26

    Article  CAS  PubMed  Google Scholar 

  71. Votrubova J, Belohlavek O, Jaruskova M et al (2006) The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 33:779–784

    Article  PubMed  Google Scholar 

  72. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–34 (discussion 1035-6)

    Google Scholar 

  73. Chua SC, Groves AM, Kayani I et al (2007) The impact of 18F-FDG PET/CT in patients with liver metastases. Eur J Nucl Med Mol Imaging 34:1906–1914

    Article  PubMed  Google Scholar 

  74. Fernandez-Trigo V, Shamsa F, Sugarbaker PH (1995) Repeat liver resections from colorectal metastasis. repeat hepatic metastases registry. Surgery 117:296–304

    Article  CAS  PubMed  Google Scholar 

  75. Vaillant JC, Balladur P, Nordlinger B et al (1993) Repeat liver resection for recurrent colorectal metastases. Br J Surg 80:340–344

    Article  CAS  PubMed  Google Scholar 

  76. Tuttle TM, Curley SA, Roh MS (1997) Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol 4:125–130

    Article  CAS  PubMed  Google Scholar 

  77. Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P (2002) Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89:752–756

    Article  CAS  PubMed  Google Scholar 

  78. Elias D, Lasser P, Hoang JM et al (1993) Repeat hepatectomy for cancer. Br J Surg 80:1557–1562

    Article  CAS  PubMed  Google Scholar 

  79. Nishio H, Hamady ZZ, Malik HZ et al (2007) Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol 33:729–734

    Article  CAS  PubMed  Google Scholar 

  80. McCall JL, Black RB, Rich CA et al (1994) The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 37:875–881

    Article  CAS  PubMed  Google Scholar 

  81. Staab HJ, Anderer FA, Stumpf E, Hornung A, Fischer R, Kieninger G (1985) Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am J Surg 149:198–204

    Article  CAS  PubMed  Google Scholar 

  82. Takahashi S, Inoue K, Konishi M, Nakagouri T, Kinoshita T (2003) Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery. 133:627–634

    Article  PubMed  Google Scholar 

  83. Suzuki S, Sakaguchi T, Yokoi Y et al (2001) Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery. 129:421–428

    Article  CAS  PubMed  Google Scholar 

  84. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K (1999) Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 178:275–281

    Article  CAS  PubMed  Google Scholar 

  85. Wray CJ, Lowy AM, Mathews JB et al (2005) The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol 12:374–380

    Article  CAS  PubMed  Google Scholar 

  86. Giantonio B, Catalana P, Meropol N et al (2007) Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539–1544

    Article  CAS  PubMed  Google Scholar 

  87. Cunningham D, Humblet Y, Siena S et al (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–345

    Article  CAS  PubMed  Google Scholar 

  88. Chung KY, Shia J, Kemeny NE et al (2005) Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol 23:1803–1810

    Article  CAS  PubMed  Google Scholar 

  89. Ciardiello F, Tortora G (2001) A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7:2958–2970

    CAS  PubMed  Google Scholar 

  90. Karapetis CS, Khambata-Ford S, Jonker DJ et al (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359:1757–1765

    Article  CAS  PubMed  Google Scholar 

  91. Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F et al (2007) Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. Cancer Res 67:2643–2648

    Article  CAS  PubMed  Google Scholar 

  92. Lievre A, Bachet JB, Boige V et al (2008) KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 26:374–379

    Article  CAS  PubMed  Google Scholar 

  93. Lievre A, Bachet JB, Le Corre D et al (2006) KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66:3992–3995

    Article  CAS  PubMed  Google Scholar 

  94. Bokemeyer C, Bondarenko I, Makhson A et al (2008) Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol

    Google Scholar 

  95. Moroni M, Veronese S, Benvenuti S et al (2005) Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 6:279–286

    Article  CAS  PubMed  Google Scholar 

  96. Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Ichikawa T, Saito K, Yoshioka N et al (2010) Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 45(3):133–141

    Article  PubMed  Google Scholar 

  98. Donati OF, Hany TF, Reiner CS et al (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 51(5):692–699

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Surgical Oncology, University of Cincinnati School of Medicine, Cincinnati, USA

    Vikrom Dhar & Syed A. Ahmad

  2. North Florida/South Georgia Veterans Health System, University of Florida College of Medicine, Gainesville, FL, USA

    Ryan M. Thomas

  3. The Barrett Cancer Center, 231 Albert Sabin Way ML 0558, SRU Room 1466, Cincinnati, OH, 45267, USA

    Syed A. Ahmad

Authors
  1. Vikrom Dhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan M. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Syed A. Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Syed A. Ahmad .

Editor information

Editors and Affiliations

  1. Department of Surgery, Northwestern University, Chicago, Illinois, USA

    David Bentrem

  2. Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA

    Al B. Benson

Appendix

Appendix

See Tables 1, 2, and 3.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dhar, V., Thomas, R.M., Ahmad, S.A. (2016). Repeat Hepatectomy for Colorectal Liver Metastases. In: Bentrem, D., Benson, A. (eds) Gastrointestinal Malignancies. Cancer Treatment and Research. Springer, Cham. https://doi.org/10.1007/978-3-319-34244-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34244-3_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34242-9

  • Online ISBN: 978-3-319-34244-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation